Increasing number of studies supported that endothelial damage, vascular inflammation, and metabolic dysfunction participate the development of HDP, such as endothelial pathway, NF-κb signaling pathway, abnormal glucose-metabolism, and dyslipidemia (33–36). Here, NFKB1 is linked to metabolic syndrome.